Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Xona | Burlingame | Series D | $250.0M | 2026-10-22 |
| Neurable | Boston | Series A | $35.0M | 2025-12-19 |
| Ramona | Durham | Series A | $25.0M | 2026-09-22 |
| Koda Health | Houston | Series A | $7.0M | 2026-04-28 |
| Kintsugi | Berkeley | Series A | $20.0M | 2022-02-28 |
| Talus Bio | Seattle | Seed | $11.2M | 2026-09-21 |
| Emvolon | Woburn | Series A | $22.0M | 2026-10-27 |
| Corelight | San Francisco | Series E | $150.0M | 2024-04-30 |
8 rows of the CSV in 5 of its 18 columns.
- The 244 National Science Foundation portfolio companies have raised $6.2B in total.
- 36 of them closed their most recent round in the last 12 months, $888.1M combined.
- The largest of those rounds is Xona's $250.0M Series D, dated October 2026.
- The most recent is Emvolon's $22.0M Series A on 27 October 2026.
- Techstars is an investor in 17 of them, more than any other fund.
- Software is the most common sector, with 171 companies (70%).
- 15% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (54% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 244| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Emvolon | Emvolon converts wasted resources into low-cost green fuels. | Energy | Woburn, United States | Series A | $22.0M | 2026-10-27 | $24.5M | National Science Foundation, MassVentures, The Engine | 11 to 50 | 2021 |
| Xona | Xona provides satellite navigation services that deliver positioning, navigation, and timing data from a low Earth orbit network. | Hardware | Burlingame, United States | Series D | $250.0M | 2026-10-22 | $582.1M | Gaingels, National Science Foundation, Creative Destruction Lab +2 | 101 to 250 | 2019 |
| MuukTest | MuukTest provides an AI-powered software testing platform that helps developers test their software faster. | Artificial intelligence | Raleigh, United States | Seed | $499K | 2026-10-14 | $7.0M | Techstars, MassChallenge, National Science Foundation +2 | 11 to 50 | 2019 |
| Ramona | Ramona develops high-throughput microscopy tools for biology labs. | Artificial intelligence | Durham, United States | Series A | $25.0M | 2026-09-22 | $59.7M | National Science Foundation, National Institutes of Health, E14 Fund +1 | 11 to 50 | 2017 |
| Talus Bio | Talus Bio develops AI-driven drugs that target transcription factors considered undruggable. | Artificial intelligence | Seattle, United States | Seed | $11.2M | 2026-09-21 | $27.8M | Y Combinator, Pioneer Fund, National Science Foundation +2 | 11 to 50 | 2020 |
| Vibronix | Vibronix develops optical and acoustic imaging and sensing technology for surgical guidance and diagnosis. | Artificial intelligence | West Lafayette, United States | Series B | $14.9M | 2026-09-14 | $31.0M | National Science Foundation, Frees Fund, Founder H Fund +1 | 11 to 50 | 2013 |
| Roboligent | Roboligent offers a robot that delivers automated physical therapy exercises to patients. | Hardware | Round Rock, United States | Seed | $2.5M | 2026-09-08 | $6.5M | Newchip Accelerator, National Science Foundation, StartEngine | 1 to 10 | 2016 |
| MALCOVA | MALCOVA delivers hardware and AI-based software solutions for needs in the radiology market. | Health care | Newark, United States | Seed | $1.2M | 2026-09-04 | $2.9M | National Science Foundation | 1 to 10 | 2020 |
| Astek Diagnostics | Astek Diagnostics guides physicians in prescribing appropriate antibiotics for patients. | Health care | Baltimore, United States | Seed | $750K | 2026-08-25 | $3.6M | Y Combinator, National Science Foundation, MedTech Innovator +2 | 1 to 10 | 2020 |
| Quintessent | Quintessent commercializes quantum dot-based lasers and photonic integrated circuits. | Artificial intelligence | Goleta, United States | Series A | $40.0M | 2026-08-24 | $53.9M | National Science Foundation, Sierra Ventures, Foothill Ventures +2 | 11 to 50 | 2019 |
| Soctera | Soctera develops Aluminium Nitride power transistors that generate MW-frequency signals. | Hardware | Ithaca, United States | Seed | $4.0M | 2026-08-11 | $5.0M | National Science Foundation | 1 to 10 | 2020 |
| Remedium Bio | Remedium Bio develops gene therapy treatments for various diseases. | Biotech | Needham, United States | Series A | $10.0M | 2026-08-10 | $13.8M | National Science Foundation, MicroVentures, Longevitytech.fund +1 | 11 to 50 | 2020 |
| Amissa Health | Amissa Health provides AI-enabled clinical decision support for perimenopause care. | Artificial intelligence | Charlotte, United States | Pre-seed | $25K | 2026-06-19 | $3.8M | National Science Foundation, NC IDEA, One North Carolina Small Business Program +2 | 1 to 10 | 2017 |
| Atom Computing | Atom Computing develops gate-based quantum computers using optically trapped neutral atoms as qubits. | Hardware | Berkeley, United States | Series C | $100.0M | 2026-06-16 | $191.2M | National Science Foundation, Export and Investment Fund, Fifty Years +1 | 101 to 250 | 2018 |
| Folio Photonics | Folio Photonics develops optical storage technology for archival data. | Hardware | Solon, United States | Series A | $8.0M | 2026-06-04 | $27.7M | National Science Foundation, Capital One Ventures, Refinery Ventures | 11 to 50 | 2012 |
| JuliaHub | JuliaHub provides a single platform for modeling, simulation, and building custom applications. | Software | Cambridge, United States | Series B | $65.0M | 2026-04-30 | $107.8M | General Catalyst, National Science Foundation, Menlo Ventures +2 | 101 to 250 | 2015 |
| Koda Health | Koda Health provides digital healthcare for advance care planning and kidney care. | Health care | Houston, United States | Series A | $7.0M | 2026-04-28 | $14.5M | Techstars, National Science Foundation, MAGIC Fund +1 | 11 to 50 | 2020 |
| InsightFinder AI | InsightFinder AI provides AI-powered observability and predictive analytics for IT operations. | Artificial intelligence | Brooklyn, United States | Series B | $15.0M | 2026-04-16 | $34.5M | National Science Foundation, Eight Roads Ventures, Propel(X) +2 | 11 to 50 | 2015 |
| MTR | MTR manufactures membrane-based separation systems for various industries. | Energy | Newark, United States | Series B | $27.0M | 2026-04-07 | $32.7M | National Science Foundation, US Department of Energy | 51 to 100 | 1982 |
| Kytopen | Kytopen develops genome engineering platforms for cell therapy research and manufacturing. | Biotech | Cambridge, United States | Series B | $1.6M | 2026-04-07 | $39.1M | National Science Foundation, MassVentures, Alexandria Venture Investments +1 | 11 to 50 | 2017 |
| EnVision Endoscopy | EnVision Endoscopy supplies medical devices and solutions used in endoscopic surgeries. | Health care | Lowell, United States | Series A | $500K | 2026-03-30 | $3.9M | MassChallenge, National Science Foundation, MassVentures +1 | 1 to 10 | 2018 |
| Ateios | Ateios develops battery manufacturing technologies and materials for thin, flexible, high-energy batteries. | Energy | Newberry, United States | Series A | $7.2M | 2026-03-23 | $11.9M | Techstars, National Science Foundation, Techstars Ventures +2 | 1 to 10 | 2018 |
| BreezeBio | BreezeBio is a biotechnology company that develops genetic therapies using non-viral delivery to clinically important tissues. | Artificial intelligence | Brisbane, United States | Series B | $60.0M | 2026-02-25 | $127.7M | Sequoia Capital, National Science Foundation, Qiming Venture Partners +1 | 51 to 100 | 2016 |
| Avisi Technologies | Avisi Technologies develops nanotechnology-based ophthalmic devices for glaucoma and related eye conditions. | Health care | Redwood City, United States | Series A | $10.8M | 2026-02-25 | $21.7M | National Science Foundation, MedTech Innovator, Ben Franklin Technology Partners of Southeastern Pennsylvania +1 | 1 to 10 | 2017 |
| Rowbot Systems | Rowbot Systems develops and provides a robotic machine that lets farmers practice in-season nitrogen management. | Hardware | Minneapolis, United States | Seed | $25K | 2026-02-18 | $281K | National Science Foundation, Invested Development | 1 to 10 | 2012 |
| Prenosis | Prenosis develops data-driven diagnostic tools and precision medicine solutions for acute care conditions. | Artificial intelligence | Chicago, United States | Series A | $20.0M | 2026-01-29 | $31.5M | National Science Foundation, PACE Healthcare Capital, Defense Threat Reduction Agency (DTRA) | 11 to 50 | 2014 |
| Think Bioscience | Think Bioscience designs and assembles medicines using living systems through synthetic biology. | Biotech | Boulder, United States | Series A | $55.0M | 2026-01-20 | $78.3M | National Science Foundation, Innovation Endeavors, Wireframe Ventures +2 | 11 to 50 | 2019 |
| NANOCHON | Nanochon develops medical implant technology for repairing cartilage in patients with joint surface damage. | Biotech | Washington, United States | Seed | $4.1M | 2026-01-12 | $14.3M | Alumni Ventures, MassChallenge, National Science Foundation +2 | 1 to 10 | 2016 |
| Neurable | Neurable develops AI tools for translating brain signals and brain-computer interface technology. | Artificial intelligence | Boston, United States | Series A | $35.0M | 2025-12-19 | $57.3M | National Science Foundation, Global Brain Corporation, Metaplanet +1 | 11 to 50 | 2015 |
| Culture Biosciences | Culture Biosciences provides automated systems for bioprocess development of biological products. | Biotech | San Francisco, United States | Series C | $80.0M | 2025-12-16 | $101.6M | Y Combinator, National Science Foundation, BoxGroup +1 | 101 to 250 | 2016 |
Table 1. National Science Foundation portfolio companies: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 244.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Xona | Xona provides satellite navigation services that deliver positioning, navigation, and timing data from a low Earth orbit network. | Hardware | Burlingame, United States | Series D | $250.0M | 2026-10-22 | $582.1M | Gaingels, National Science Foundation, Creative Destruction Lab +2 | 101 to 250 | 2019 |
| 2 | Atom Computing | Atom Computing develops gate-based quantum computers using optically trapped neutral atoms as qubits. | Hardware | Berkeley, United States | Series C | $100.0M | 2026-06-16 | $191.2M | National Science Foundation, Export and Investment Fund, Fifty Years +1 | 101 to 250 | 2018 |
| 3 | Culture Biosciences | Culture Biosciences provides automated systems for bioprocess development of biological products. | Biotech | San Francisco, United States | Series C | $80.0M | 2025-12-16 | $101.6M | Y Combinator, National Science Foundation, BoxGroup +1 | 101 to 250 | 2016 |
| 4 | JuliaHub | JuliaHub provides a single platform for modeling, simulation, and building custom applications. | Software | Cambridge, United States | Series B | $65.0M | 2026-04-30 | $107.8M | General Catalyst, National Science Foundation, Menlo Ventures +2 | 101 to 250 | 2015 |
| 5 | BreezeBio | BreezeBio is a biotechnology company that develops genetic therapies using non-viral delivery to clinically important tissues. | Artificial intelligence | Brisbane, United States | Series B | $60.0M | 2026-02-25 | $127.7M | Sequoia Capital, National Science Foundation, Qiming Venture Partners +1 | 51 to 100 | 2016 |
| 6 | Think Bioscience | Think Bioscience designs and assembles medicines using living systems through synthetic biology. | Biotech | Boulder, United States | Series A | $55.0M | 2026-01-20 | $78.3M | National Science Foundation, Innovation Endeavors, Wireframe Ventures +2 | 11 to 50 | 2019 |
| 7 | Quintessent | Quintessent commercializes quantum dot-based lasers and photonic integrated circuits. | Artificial intelligence | Goleta, United States | Series A | $40.0M | 2026-08-24 | $53.9M | National Science Foundation, Sierra Ventures, Foothill Ventures +2 | 11 to 50 | 2019 |
| 8 | Neurable | Neurable develops AI tools for translating brain signals and brain-computer interface technology. | Artificial intelligence | Boston, United States | Series A | $35.0M | 2025-12-19 | $57.3M | National Science Foundation, Global Brain Corporation, Metaplanet +1 | 11 to 50 | 2015 |
| 9 | MTR | MTR manufactures membrane-based separation systems for various industries. | Energy | Newark, United States | Series B | $27.0M | 2026-04-07 | $32.7M | National Science Foundation, US Department of Energy | 51 to 100 | 1982 |
| 10 | Ramona | Ramona develops high-throughput microscopy tools for biology labs. | Artificial intelligence | Durham, United States | Series A | $25.0M | 2026-09-22 | $59.7M | National Science Foundation, National Institutes of Health, E14 Fund +1 | 11 to 50 | 2017 |
Table 2. National Science Foundation portfolio companies: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Techstars | Startup accelerator | New York, United States | 17 | 7% | 3 | MuukTest, Koda Health, Ateios |
| 2 | MassChallenge | Startup accelerator | Boston, United States | 13 | 5% | 5 | MuukTest, Astrileux, EnVision Endoscopy |
| 3 | Alumni Ventures | Angel group | Manchester, United States | 12 | 5% | 2 | NANOCHON, Vertiq |
| 4 | National Institutes of Health | Entrepreneurship program | Bethesda, United States | 8 | 3% | 2 | Ramona, Talus Bio |
| 5 | Y Combinator | Startup accelerator | Mountain View, United States | 8 | 3% | 3 | Talus Bio, Astek Diagnostics, Culture Biosciences |
| 6 | SOSV | Venture capital firm | Princeton, United States | 8 | 3% | 2 | Strados Labs, Vertiq |
| 7 | US Department of Energy | Government investment office | Washington, United States | 7 | 3% | 1 | MTR |
| 8 | Creative Destruction Lab | Entrepreneurship program | Toronto, Canada | 6 | 2% | 2 | Xona, NANOCHON |
| 9 | MassVentures | Venture capital firm | Boston, United States | 6 | 2% | 3 | Emvolon, Kytopen, EnVision Endoscopy |
| 10 | Gaingels | Syndicate | Burlington, United States | 5 | 2% | 1 | Xona |
| 11 | Toyota Ventures | Corporate venture arm | Los Altos, United States | 5 | 2% | 1 | Xona |
| 12 | Khosla Ventures | Venture capital firm | Menlo Park, United States | 5 | 2% | ||
| 13 | Alchemist Accelerator | Startup accelerator | San Francisco, United States | 5 | 2% | ||
| 14 | MedTech Innovator | Startup accelerator | Los Angeles, United States | 5 | 2% | 3 | Astek Diagnostics, Avisi Technologies, NANOCHON |
| 15 | Intel Capital | Corporate venture arm | Santa Clara, United States | 5 | 2% |
Table 3. National Science Foundation portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 171 | 70% | $3.3B |
| Hardware | 93 | 38% | $2.4B |
| Artificial intelligence | 80 | 33% | $1.6B |
| Health care | 66 | 27% | $2.2B |
| Biotech | 49 | 20% | $1.9B |
| Energy | 17 | 7% | $264.6M |
| Education | 13 | 5% | $166.1M |
| Cybersecurity | 11 | 5% | $383.2M |
| Fintech | 4 | 2% | $18.2M |
| Commerce | 4 | 2% | $5.3M |
Table 4. National Science Foundation portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. National Science Foundation portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| San Francisco | 16 | 7% |
| Boston | 11 | 5% |
| New York | 11 | 5% |
| Berkeley | 10 | 4% |
| Cambridge | 8 | 3% |
| Pittsburgh | 7 | 3% |
| Seattle | 6 | 2% |
| Chicago | 6 | 2% |
| Philadelphia | 6 | 2% |
| Boulder | 5 | 2% |
| Irvine | 5 | 2% |
| Houston | 4 | 2% |
Table 6. National Science Foundation portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 3 | 8% | $272.5M |
| September 2026 | 5 | 14% | $54.8M |
| August 2026 | 5 | 14% | $54.8M |
| June 2026 | 3 | 8% | $108.0M |
| April 2026 | 5 | 14% | $115.6M |
| March 2026 | 2 | 6% | $7.7M |
| February 2026 | 4 | 11% | $74.8M |
| January 2026 | 4 | 11% | $79.1M |
| December 2025 | 2 | 6% | $115.0M |
| November 2025 | 3 | 8% | $5.8M |
Table 7. National Science Foundation portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 31 | 13% | $767.3M |
| 2025 | 25 | 10% | $329.6M |
| 2024 | 38 | 16% | $788.5M |
| 2023 | 41 | 17% | $221.5M |
| 2022 | 22 | 9% | $271.2M |
| 2021 | 22 | 9% | $488.6M |
Table 8. National Science Foundation portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 3 | 1% |
| 2020 to 2022 | 33 | 14% |
| 2015 to 2019 | 128 | 52% |
| 2010 to 2014 | 64 | 26% |
| Before 2010 | 16 | 7% |
Table 9. National Science Foundation portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 75 | 31% |
| 11 to 50 | 132 | 54% |
| 51 to 100 | 15 | 6% |
| 101 to 250 | 18 | 7% |
| 251 to 500 | 3 | 1% |
| 10,001 or more | 1 | 0% |
Table 10. National Science Foundation portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when National Science Foundation is recorded as one of its investors. On 16 November 2026 that is 244 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 244 rows: 38 have no round amount, 0 no city and 15 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many National Science Foundation portfolio companies are on the list?
- 244, in the file dated 16 November 2026. 36 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 244 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.